PubMed · 2001 · 91 citations · 30 references
Life SciencesGeneticsImmunologyGastrointestinal OncologyGenetic EpidemiologyImmunogeneticsGastric CancerGastric DiseasesGastrointestinal ImmunologyHla TypingMajor Histocompatibility ComplexTumor AntigensGastric Cancer GeneticsHelicobacter Pylori InfectionHelicobacter Pylori-associated Gastric CarcinogenesisHelicobacter-associated Gastric CarcinogenesisHla Allele PolymorphismHla AllelesHla Class Ii MoleculesHla Risk Alleles
DNA and sera from 130 cases of gastric cancer and 263 population-based controls were analyzed to study the association of HLA class II DR-DQ alleles with Helicobacter pylori (Hp) infection and the risk for gastric cancer. Presence of the DQA1*0102 allele was inversely and significantly associated with Hp seropositivity (P = 2 x 10(-5)), which is an independent replication of previous findings. However, this inverse relationship with Hp did not correspond with a reduced risk of gastric cancer. At the DRB1 locus, the *1601 allele was significantly associated with an increased gastric cancer risk with an odds ratio (95% confidence interval) of 8.7 (range, 2.7-28.0). The effect of *1601 was more pronounced among Hp-negative subjects, and the association was stronger with the diffuse, rather than with the intestinal, histological type of gastric cancer. Because none of the HLA alleles were associated with both Hp infection and gastric cancer, the HLA DR-DQ alleles are linked with gastric cancer risk through other mechanisms than an increased susceptibility to Hp infection.
30
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
Emad El‐Omar, Mary Carrington, Wong-Ho Chow et al. · Nature · 2000 · 2.4K citations
Life Sciences, Genetics, Immunology +16
E-cadherin germline mutations in familial gastric cancer
Parry Guilford, Justin Hopkins, James Harraway et al. · Nature · 1998 · 1.7K citations
Familial gastric cancer: overview and guidelines for management.
Carlos Caldas, Fátima Carneiro, Henry T. Lynch et al. · PubMed · 1999 · 509 citations
Life Sciences, Genetics, Oncology +17